Intralife Logo
Enquire Now
Empasug-LG 10mg
DIASAGE
FeaturedTop

Empasug-LG 10mg

MRP: 33

Packaging: 10X10

Pack Type: tablet

Composition:

Empagliflozin 10 mg + Linagliptin 5 mg IR

Indication:

Used in adults with type 2 diabetes mellitus (T2DM) to improve blood sugar control as an adjunct to diet and exercise. Combines SGLT2 inhibitor (Empagliflozin) and DPP-4 inhibitor (Linagliptin) for dual action on glucose regulation. Not for type 1 diabetes or diabetic ketoacidosis.

Description:

Empagliflozin 10mg + Linagliptin 5mg IR is a fixed-dose combination oral medication used to manage type 2 diabetes mellitus. This dual-action tablet combines two powerful antidiabetic agents with complementary mechanisms:

  • Empagliflozin (10mg): A Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor that lowers blood sugar by promoting glucose excretion through urine.

  • Linagliptin (5mg): A Dipeptidyl Peptidase-4 (DPP-4) inhibitor that increases insulin secretion and decreases glucagon levels in a glucose-dependent manner.

Together, this combination helps improve glycemic control by reducing blood glucose through insulin-dependent and insulin-independent pathways. It is designed for patients who require enhanced blood sugar management and benefits from weight neutrality or mild weight loss. The immediate-release (IR) formulation allows for quick absorption and effective action.

Tags:

Type 2 Diabetes Combination Therapy SGLT2 Inhibitors DPP-4 Inhibitors Oral Antidiabetics Immediate Release Prescription Medicines
  • Dual mechanism improves blood sugar control
  • Supports weight loss or is weight-neutral
  • Lowers risk of hypoglycemia compared to some therapies
  • Improves insulin sensitivity and secretion
  • Convenient once-daily dosing enhances adherence
  • Cardiovascular benefits linked to Empagliflozin

Usage Information

Dosage

Take one tablet once daily at the same time each day. Can be taken with or without meals. Follow your healthcare provider’s instructions on dose adjustments. Regular monitoring of blood glucose is recommended.

Side Effects

Common side effects: Increased urination Upper respiratory tract infections Nasopharyngitis (common cold symptoms) Genital yeast infections Mild gastrointestinal discomfort Serious side effects (rare): Diabetic ketoacidosis (even with normal blood sugar) Severe allergic reactions Acute kidney injury Hypotension, dehydration

Contraindications

Type 1 diabetes mellitus Diabetic ketoacidosis Severe renal impairment (eGFR < 30 mL/min/1.73m²) Hypersensitivity to Empagliflozin, Linagliptin, or excipients History of pancreatitis (caution advised) Conditions predisposing to ketoacidosis